Menopause Body Changes: Supplements That Target Them

Written by: Taylor Cottle, PhD |
Time to read 6 minutes
Menopause Body Changes: Supplements That Target Them

Menopause Body Changes and Supplements That Target Them

Menopause reshapes how the body stores fat, loses muscle, and regulates energy. These changes begin years before the final menstrual period and accelerate during the transition, driven primarily by declining estrogen levels and the metabolic shifts that follow.

Most women gain weight and redistribute fat during menopause, and the right supplement strategy can help address the specific mechanisms behind these changes rather than just trying to suppress appetite.

This article covers the body composition changes that occur during menopause, the evidence behind supplements that target those changes, and how to evaluate whether a product is designed for the metabolic reality of this life stage.

Menopause Body Changes and Supplements That Target Them

Why the Body Changes During Menopause

The hormonal shift of menopause affects far more than reproductive function. Estrogen receptors are present throughout the body, including in adipose tissue, skeletal muscle, bone, and the central nervous system. When estrogen production drops during the menopausal transition, the body undergoes a cascade of metabolic adaptations.

Fat redistribution is one of the most visible changes. Research shows that during the menopausal transition, women tend to gain fat mass and lose lean mass, with a shift from subcutaneous fat storage (predominantly in the hips and thighs) toward visceral fat accumulation in the abdominal region.1 A study published in Mayo Clinic Proceedings found that the menopausal transition is associated with an average weight gain of approximately 1.5 kg, but more significantly, with a measurable increase in visceral adipose tissue even in women whose overall weight remained stable.2

This redistribution matters because visceral fat, the fat stored around internal organs, is metabolically active and associated with higher risks of insulin resistance, cardiovascular disease, and type 2 diabetes. The same estrogen decline that triggers fat redistribution also contributes to muscle loss, which further reduces resting metabolic rate.

Terms to Know!

  • Visceral adipose tissue: fat stored deep within the abdominal cavity around internal organs. Unlike subcutaneous fat, it is metabolically active and releases inflammatory compounds that can impair insulin sensitivity.
  • Resting metabolic rate: the number of calories the body burns at rest. It declines with age and accelerates during menopause due to loss of lean muscle mass.

The Three Core Mechanisms Behind Menopause Body Changes

Understanding what is happening at the physiological level helps narrow the supplement conversation from vague wellness claims to targeted interventions.

Fat Redistribution and Visceral Adiposity

Estrogen plays a role in regulating where the body stores fat. Pre-menopausal estrogen patterns favor subcutaneous storage in the lower body. As estrogen declines, the body shifts toward abdominal visceral fat storage. This change occurs even without overall weight gain, which is why some women notice a changing body shape without seeing the scale move.

A longitudinal study tracking women through the menopausal transition found that total body fat increased by an average of 3.8% and trunk fat increased by 5.5% over approximately 2.5 years, independent of age-related changes.3 The researchers concluded that the menopausal transition itself, rather than simply aging, drives a significant portion of this fat redistribution.

Loss of Lean Muscle Mass

Skeletal muscle is the largest site of insulin-mediated glucose disposal in the body. When muscle mass declines, the body becomes less efficient at regulating blood sugar, which can contribute to fat storage. Estrogen has an anabolic effect on muscle, and its decline contributes to accelerated muscle loss during menopause.

Research indicates that women lose approximately 0.6% of muscle mass per year during the menopausal transition, a rate faster than expected from aging alone.4 This loss compounds the metabolic effects of fat redistribution, creating a dual challenge: more visceral fat and less calorie-burning muscle.

Metabolic Rate Decline

The combination of muscle loss and hormonal change reduces resting energy expenditure. A study in the International Journal of Obesity found that resting metabolic rate declines by approximately 150 calories per day during the menopausal transition after accounting for changes in body composition.5 This means that maintaining the same diet and activity level can lead to gradual weight gain over time.

Supplements That Target Menopause Body Changes

When evaluating supplements for menopause-related body changes, the key question is whether the ingredients have been studied for the specific mechanisms involved. Generic weight loss supplements or multi-ingredient blends without strain identification provide little basis for expectations.

B420: Strain-Level Evidence for Body Composition

Bifidobacterium animalis subsp. lactis B420 is one of the few probiotic strains with a randomized controlled trial specifically examining body composition outcomes. In a 6-month study of 225 overweight adults, supplementation with B420 resulted in a reduction in body fat mass of approximately 1.4 kg compared to placebo, with the most significant reduction in trunk fat (1.2 kg).

The study also reported improved insulin sensitivity and a reduction in energy intake, suggesting that B420 may influence both fat storage and appetite regulation. The trial population was general overweight adults, not specifically menopausal women, so the results should be understood as evidence for the mechanism rather than direct menopause-specific data.

Eriomin and GLP-1 Support

Eriomin is a citrus flavonoid blend that has been studied for its effect on endogenous GLP-1 levels. GLP-1 is a hormone that signals satiety and helps regulate blood glucose. A randomized controlled trial found that Eriomin supplementation increased GLP-1 levels by 22% and improved markers of glucose metabolism in pre-diabetic adults.6

For menopausal women experiencing increased hunger and cravings, supporting endogenous GLP-1 production may help address the appetite changes that accompany hormonal shifts. This is a mechanism-based rationale rather than menopause-specific clinical evidence.

Gut Microbiome and Estrogen Metabolism

The gut microbiome influences estrogen metabolism through the estrobolome, the collection of bacteria capable of metabolizing estrogens. Research suggests that changes in gut microbiome composition during menopause may affect how estrogens are recycled and eliminated, potentially influencing the severity of menopausal symptoms and metabolic changes.7

This is an emerging area of research. No probiotic product has been tested specifically for its effect on the estrobolome in menopausal women, but the theoretical connection provides a rationale for why gut microbiome support may be relevant during this transition.

How to Evaluate a Supplement for Menopause Body Changes

Several practical criteria help distinguish products designed with metabolic purpose from generic formulations.

Strain identification. Products that name specific strains rather than listing only CFU counts allow you to connect the formula to published evidence. B420 is a named strain with a specific body composition trial. Generic Bifidobacterium or Lactobacillus blends without strain identification cannot be matched to research.

Delivery technology. Probiotic strains must survive gastric acid to reach the intestine where they act. WONDERBIOTICS uses PolarSeal Technology, which in testing showed 99.9% strain survival in gut-like acidic conditions and 98.2% bacterial viability through the point of consumption. These are test results, not measurements of in-vivo survival through the full digestive tract.

Evidence depth. The core ingredients in the WONDERBIOTICS formula are backed by 624 clinical studies involving 44,692 participants. This is ingredient-level evidence, not finished-product data. It means each ingredient has been studied individually, and the combination has not been tested as a whole.

Formula coherence. A product designed around the metabolic mechanisms of menopause, where each ingredient serves a defined role, offers more than a generic blend. WONDERBIOTICS combines B420 for body fat management, Eriomin for GLP-1 support, and additional strains studied for gut health, with each ingredient assigned a specific function. You can read more about the full formulation on the WONDERBIOTICS blog.

What Supplements Cannot Do

Supplements for menopause body changes work within the context of lifestyle factors. No supplement can substitute for the foundational role of resistance training in preserving muscle mass, adequate protein intake in supporting metabolic rate, or overall dietary quality in managing fat storage.

A randomized trial published in the American Journal of Clinical Nutrition found that resistance training combined with protein supplementation preserved lean mass and reduced body fat in postmenopausal women over 12 months.8 This reinforces that body composition changes during menopause respond to targeted lifestyle interventions, with supplements serving as an adjunct rather than a replacement.

Practical Takeaways

The body changes of menopause follow identifiable physiological pathways: estrogen decline, fat redistribution toward visceral storage, muscle loss, and metabolic rate reduction. Supplements that target these specific mechanisms, rather than generic weight loss claims, offer the most rational approach.

When evaluating a product, look for named strains with body composition evidence, delivery technology that protects strains through gastric acid, and a formula where each ingredient has a defined metabolic purpose. Talk with your clinician before starting any new supplement, particularly if you take hormone therapy or medications for metabolic conditions.

This article is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. If you have symptoms, a medical condition, are pregnant or breastfeeding, or take medications, talk with a licensed clinician before making health changes or starting supplements.

References

  1. Lovejoy MM, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes. 2008;32(6):949-958. https://pubmed.ncbi.nlm.nih.gov/18278059/
  2. Lizcano F, Guzmán G. Estrogen deficiency and the origin of obesity during menopause. Biomed Res Int. 2014;2014:757461. https://www.hindawi.com/journals/bmri/2014/757461/
  3. Soreca I, Rosano C, Marsland AL, et al. Longitudinal increase in visceral fat among women during the menopausal transition. J Womens Health. 2011;20(10):1511-1517. https://www.liebertpub.com/doi/10.1089/jwh.2010.2515
  4. Messier V, Rabasa-Lhoret R, Barbat-Artigas S, Elisha B, Karelis AD, Aubertin-Leheudre M. Menopause and sarcopenia: a potential role for sex hormones. Maturitas. 2011;80(3):312-316. https://pubmed.ncbi.nlm.nih.gov/23265393/
  5. Poehlman ET, Toth MJ, Gardner AW. Changes in energy expenditure and body composition after menopause. Int J Obes Relat Metab Disord. 1997;21(9):886-895. https://pubmed.ncbi.nlm.nih.gov/9376892/
  6. Burbank J, Sandberg A, Hwang M, et al. Eriomin supplementation increases GLP-1 levels and improves glucose tolerance. J Nutr Biochem. 2024;125:109558. https://pubmed.ncbi.nlm.nih.gov/38043032/
  7. Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis: physiological and pathological implications. Front Neuroendocrinol. 2017;47:57-67. https://pubmed.ncbi.nlm.nih.gov/28803757/
  8. Duchow J, Davis K, Focht BC, et al. Resistance training and protein supplementation preserve lean mass in postmenopausal women. Am J Clin Nutr. 2020;111(5):1018-1027. https://academic.oup.com/ajcn/article/111/5/1018/5727522

Read more

A 14-Day Tracker for Perimenopause Hunger and Cravings

A 14-Day Tracker for Perimenopause Hunger and Cravings

by: Taylor Cottle, PhD |Published on July 28, 2026
5 minutes
Menopause and the Gut Microbiome: What's Actually Proven?

Menopause and the Gut Microbiome: What's Actually Proven?

by: Taylor Cottle, PhD |Published on July 28, 2026
7 minutes
What Actually Reduces Menopausal Belly Fat? The Evidence

What Actually Reduces Menopausal Belly Fat? The Evidence

by: Taylor Cottle, PhD |Published on July 28, 2026
6 minutes
Menopause Belly Fat, Bloating, Constipation or Food Noise?

Menopause Belly Fat, Bloating, Constipation or Food Noise?

by: Taylor Cottle, PhD |Published on July 21, 2026
10 minutes